Eurofins Scient (OTCMKTS:ERFSF) Trading 5.1% Higher - Here's Why

Key Points

• Shares rose 5.1% to $74.63 on Friday, but trading was thin at about 2,691 shares—roughly 60% below the stock's average daily volume.
• Analyst activity is mixed: BNP Paribas Exane upgraded Eurofins to "outperform", yet the MarketBeat consensus remains "Hold" (one Buy, three Holds).
• Key metrics show a debt-to-equity ratio of 0.77 and a current ratio of 1.26, and the stock is trading below its 50-day SMA ($78.39) but roughly in line with its 200-day SMA ($74.56).

Shares of Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) rose 5.1% during trading on Friday . The company traded as high as $74.63 and last traded at $74.63. Approximately 2,691 shares were traded during mid-day trading, a decline of 60% from the average daily volume of 6,664 shares. The stock had previously closed at $70.98.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on ERFSF shares. BNP Paribas Exane upgraded shares of Eurofins Scient to an "outperform" rating in a research note on Monday, January 5th. Citigroup reiterated a "neutral" rating on shares of Eurofins Scient in a research report on Monday, February 2nd. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold".

Eurofins Scient Trading Up 5.1%

The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19. The stock has a 50-day simple moving average of $78.39 and a 200-day simple moving average of $74.56.

About Eurofins Scient

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.